192 related articles for article (PubMed ID: 21183299)
21. Evaluation of the diagnostic performance of an oral fluid screening test device for substance abuse at traffic controls.
Avcioglu G; Yilmaz G; Yalcin Sahiner S; Kozaci LD; Bal C; Yilmaz FM
Clin Biochem; 2021 Jul; 93():112-118. PubMed ID: 33882283
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of three rapid oral fluid test devices on the screening of multiple drugs of abuse including ketamine.
Tang MHY; Ching CK; Poon S; Chan SSS; Ng WY; Lam M; Wong CK; Pao R; Lau A; Mak TWL
Forensic Sci Int; 2018 May; 286():113-120. PubMed ID: 29574346
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of the Cozart DDS oral fluid collection device.
Speedy T; Baldwin D; Jowett G; Gallina M; Jehanli A
Forensic Sci Int; 2007 Aug; 170(2-3):117-20. PubMed ID: 17624706
[TBL] [Abstract][Full Text] [Related]
24. Drugs and driving: the Finnish perspective.
Lillsunde P; Gunnar T
Bull Narc; 2005; 57(1-2):213-29. PubMed ID: 21338023
[TBL] [Abstract][Full Text] [Related]
25. Detection of illicit drugs in oral fluid from drivers as biomarker for drugs in blood.
Gjerde H; Langel K; Favretto D; Verstraete AG
Forensic Sci Int; 2015 Nov; 256():42-5. PubMed ID: 26295911
[TBL] [Abstract][Full Text] [Related]
26. On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users.
Samyn N; van Haeren C
Int J Legal Med; 2000; 113(3):150-4. PubMed ID: 10876986
[TBL] [Abstract][Full Text] [Related]
27. The incidence of drugs of impairment in oral fluid from random roadside testing.
Chu M; Gerostamoulos D; Beyer J; Rodda L; Boorman M; Drummer OH
Forensic Sci Int; 2012 Feb; 215(1-3):28-31. PubMed ID: 21665392
[TBL] [Abstract][Full Text] [Related]
28. On-site testing of illicit drugs: the use of the drug-testing device "Toxiquick".
Biermann T; Schwarze B; Zedler B; Betz P
Forensic Sci Int; 2004 Jun; 143(1):21-5. PubMed ID: 15177627
[TBL] [Abstract][Full Text] [Related]
29. Presence of psychoactive substances in oral fluid from randomly selected drivers in Denmark.
Simonsen KW; Steentoft A; Hels T; Bernhoft IM; Rasmussen BS; Linnet K
Forensic Sci Int; 2012 Sep; 221(1-3):33-8. PubMed ID: 22554868
[TBL] [Abstract][Full Text] [Related]
30. Detection and prevalence of drug use in arrested drivers using the Dräger Drug Test 5000 and Affiniton DrugWipe oral fluid drug screening devices.
Logan BK; Mohr AL; Talpins SK
J Anal Toxicol; 2014 Sep; 38(7):444-50. PubMed ID: 24894458
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of driving with blood drug concentrations above proposed new legal limits in Norway: estimations based on drug concentrations in oral fluid.
Gjerde H; Normann PT; Christophersen AS; Mørland J
Forensic Sci Int; 2011 Jul; 210(1-3):221-7. PubMed ID: 21482055
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the IDS One-Step ELISA kits for the detection of illicit drugs in hair.
Pujol ML; Cirimele V; Tritsch PJ; Villain M; Kintz P
Forensic Sci Int; 2007 Aug; 170(2-3):189-92. PubMed ID: 17628371
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the Cozart RapiScan drug test system for opiates and cocaine in oral fluid.
Cooper G; Wilson L; Reid C; Main L; Hand C
Forensic Sci Int; 2005 Jun; 150(2-3):239-43. PubMed ID: 15944065
[TBL] [Abstract][Full Text] [Related]
34. Trends in drivers testing positive for drugs of abuse in oral fluid from 2018 to 2021 in France.
Willeman T; Bartolli M; Jourdil JF; Vial S; Eysseric-Guérin H; Stanke-Labesque F
Forensic Sci Int; 2023 Nov; 352():111835. PubMed ID: 37748427
[TBL] [Abstract][Full Text] [Related]
35. Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid.
Laloup M; Tilman G; Maes V; De Boeck G; Wallemacq P; Ramaekers J; Samyn N
Forensic Sci Int; 2005 Oct; 153(1):29-37. PubMed ID: 15922530
[TBL] [Abstract][Full Text] [Related]
36. Analytical evaluation of a rapid on-site oral fluid drug test.
Goessaert AS; Pil K; Veramme J; Verstraete A
Anal Bioanal Chem; 2010 Apr; 396(7):2461-8. PubMed ID: 20140665
[TBL] [Abstract][Full Text] [Related]
37. Oral fluid testing for cannabis: on-site OraLine IV s.a.t. device versus GC/MS.
Cirimele V; Villain M; Mura P; Bernard M; Kintz P
Forensic Sci Int; 2006 Sep; 161(2-3):180-4. PubMed ID: 16854544
[TBL] [Abstract][Full Text] [Related]
38. Analytical evaluation of four on-site oral fluid drug testing devices.
Vanstechelman S; Isalberti C; Van der Linden T; Pil K; Legrand SA; Verstraete AG
J Anal Toxicol; 2012 Mar; 36(2):136-40. PubMed ID: 22337784
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Dräger DrugTest 5000 in a Naturalistic Setting.
Gjerde H; Clausen GB; Andreassen E; Furuhaugen H
J Anal Toxicol; 2018 May; 42(4):248-254. PubMed ID: 29409046
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the Cozart DDSV test for cannabis in oral fluid.
Kintz P; Brunet B; Muller JF; Serra W; Villain M; Cirimele V; Mura P
Ther Drug Monit; 2009 Feb; 31(1):131-4. PubMed ID: 19155965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
